(Q44406903)

2 December 2017

title

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy (English)

1 reference

2 December 2017

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

25 December 2023

author name string

John Miller

2

1 reference

2 December 2017

Andrew Carr

4

1 reference

2 December 2017

Patrick W. Mallon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700446

25 December 2023

David A. Cooper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700446

25 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

2 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12700446

25 December 2023

1 reference

2 December 2017

volume

17

1 reference

2 December 2017

issue

7

1 reference

2 December 2017

page(s)

971-979

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Visceral abdominal-fat accumulation associated with use of indinavir

25 December 2023

2

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

25 December 2023

3

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

25 December 2023

4

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

25 December 2023

5

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

25 December 2023

6

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

25 December 2023

8

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

25 December 2023

9

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

25 December 2023

10

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia

25 December 2023

15

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Metabolic effects of indinavir in healthy HIV-seronegative men

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy

25 December 2023

18

1 reference

https://api.crossref.org/works/10.1097/00002030-200305020-00005

25 December 2023

Identifiers

1 reference

2 December 2017

1 reference